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Multiple Sclerosis (MS) is an 
autoimmune process characterized by 
inflammation and demyelination of 
axons in the brain and spinal cord 
(Schneider, 2005).   According to 
Maclean (2010), MS is one of the most 
common debilitating neurological 
disorders in young adults.  My intent 
of this research project is to explain 
the pathophysiological process and 
become familiar with the implications 
of anesthesia related to MS.  This 
research will enable me to prepare a 
safe, individualized anesthetic plan, 
taking all essential precautions when 
caring for a patient with multiple 
sclerosis. 
 
Symptomology 
Symptoms associated with MS are 
expressed with varying degrees of 
severity and can originate at different 
times and locations throughout the 
disease process.  The variability and 
ambiguous nature of the symptoms pose 
a challenge to physicians when 
attempting to diagnose an individual 
with MS. The symptomology of MS can 
be categorized as subjective or 
objective.   
Subjective symptoms: 
 
Objective Symptoms: 
 • Tremors 
•  Ataxia  
• Dysarthria  
        (Maclean, 2010)  
• Pain          
• Fatigue 
• Trigeminal Neuralgia 
• Muscles Spasms 
• Weakness 
• Parasthesias 
• Cognitive Deficits 
• Visual Disturbances 
• Mood Instability 
• Sexual Dysfunction 
• Bladder and Bowel Dysfunction 
                                               (Maclean, 2010)  
 
Pathophysiological Process 
 Underlying pathophysiology:  
The etiology of MS is unclear, however there is speculation that the activation of 
auto-reactive T lymphocytes occur secondary to the exposure to environmental 
factors, an infectious process or viruses ( Ward-Abel, Vernon, & Warner, 2014).  After 
T lymphocytes are activated, they infiltrate the central nervous system (CNS), by 
breaking through the blood brain barrier.  T lymphocytes also activate an 
inflammatory cascade, which encompasses CD4+ and  CD8+ T cells, B cells, interleukin 
1, 6, and 11,  and tumor necrosis factor, leading to the destruction of 
oligodendrocytes and myelin (Gupta et al., 2014).  Destruction of oligodendrocytes, 
cells that produce myelin, inhibits the body’s ability to remyelinate neurons over time, 
leading to scar tissue formation on the neuron and the development of MS lesions 
(Schneider, 2005).  Demyelination impedes conduction and transmission of nerve 
impulses, thus creating cognitive and motor complications throughout the body.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significance of pathophysiology related to anesthesia:   
The pathophysiological significance of MS is individualistic.  The severity of ones 
illness ranges from benign symptoms to a debilitating disease process, which guides 
healthcare providers in their plan of treatment.  The four conceptions that are 
thought to provoke a relapse of MS symptoms are, infection, the post partum period, 
high stress environments, and hyperthermia (Ward-Abel et al., 2014).  Therefore, it is 
paramount that anesthesia providers conduct an extensive review of one’s surgical, 
medical and family history in order to create a safe plan for anesthesia.  In 
combination with a detailed history, the nurse anesthetist (NA) must also conduct a 
thorough head to toe assessment.  The physical assessment provides insight 
regarding physical frailties, such as respiratory, cardiovascular, neurological or bowel 
complications that the individual may experience, which further guides the nurse 
anesthetist’s plan for anesthesia.  Patient education is also vital to the prevention of 
MS relapse during the pre and postoperative phases.   
 
 
[How Multiple Sclerosis Works] (2008). Retrieved from 
http://s.hswstatic.com/gif/multiple-sclerosis-monocytes.jpg 
Types of Multiple Sclerosis 
Types of MS Primary progressive Relapsing-remitting Secondary progressive 
Percentage of people 15 85 N/A 
Description Symptoms appear and get 
worse (progression) from the 
start. Relapses are rare. For 
those people who have 
relapses as well as 
progression from the start, 
the term ‘progressive 
relapsing MS’ is used.  
 
Symptoms appear (relapse) 
then resolve, partially or fully 
(remission). Relapses last for 
at least 24 hours, but 
commonly last for weeks or 
months. Remissions can last 
for weeks or even years. A 
relapse is an episode of 
neurological disturbance, 
caused by inflammation or 
demyelination, which occurs 
at least 30 days after any 
previous episode began, lasts 
at least 24 hours and is not 
caused by infection or any 
other known cause (McDonald 
et al 2001).   
 
More than 65% of people who 
are initially diagnosed with 
relapsing-remitting MS will 
enter this phase within  
15 years of being diagnosed 
(Koch et al 2008). Secondary 
progression occurs when 
someone has a sustained 
progression of MS without 
any relapses having taken 
place. Some people may 
continue  
to have relapses.  
 
 
 
(MacLean, 2010) 
Implications for Anesthesia 
 
According to Schneider (2005), the stress of surgery and use of 
anesthetic agents will not lead to an exacerbation of MS symptoms, 
yet the complications of surgery, such as infection and hyperthermia 
have the potential to trigger a relapse.  The anesthesia provider must 
consider the individual’s severity of debilitation when devising an 
anesthetic plan.  If the patient has respiratory weakness secondary to 
MS, then the NA would likely elect to place the patient under general 
anesthesia, to mechanically ventilate the patient (Schneider, 2005).  
Depending on the severity of weakness the patient may be difficult to 
extubate immediately after the operation, so a plan should be made 
with the intensive care team for postoperative care.   Temperature 
control is crucial for all MS patients.  Demyelinated axons are 
sensitive to increases in a patient’s body temperature, further 
blocking the conduction of nerve impulses (Schneider, 2005).  Studies 
show that an increase of 1° C can be significant and exacerbation of 
symptoms could ensue (Schneider, 2005).  Therefore, the NA should 
have a cooling blanket under the patient prior to positioning for 
surgery.   
Knowing an individual’s degree of illness enables the NA to choose 
the appropriate neuromuscular blocking agent.  Individuals who 
exhibit extreme muscle weakness and atrophy are known to release 
excessive potassium from their cells after administration of 
succinylcholine, which could be devastating to an individual with MS 
who also has heart disease (Schneider, 2005). 
Nondepolarizing neuromuscular blocking agents have been proven 
to be safe for administration, but the effects can be prolonged or 
resistant depending once again, on the individual’s degree of 
neuromuscular involvement (Schneider, 2005).   
Important considerations when discussing regional anesthesia, often 
used during labor and delivery, cesarean sections, and orthopedic 
cases is the use of epidural versus spinal approaches to anesthesia.  
Studies have shown that the use of spinal anesthesia has led to 
exacerbations in MS symptoms along with having a higher risk of 
nerve damage (Schneider, 2005).  Epidural anesthesia and 
peripheral nerve blocks are safe, effective and are the preferred 
routes of regional anesthesia, when caring for a patient with MS 
(Schneider, 2005).   
Lastly, bowel dysfunction is a major problem for some individuals 
with MS.  It is well known that general anesthesia often creates a 
temporary postoperative ileus.  Consequently, it is important for the 
NA to ensure the patient is on a bowel regimen including 
ambulation, stool softeners, and prokinetic medications if needed.   
 
Conclusion 
 In conclusion, Multiple Sclerosis is an 
autoimmune process leading to the 
demyelination of axons, which slows the 
conduction and transmission of nerve 
impulses throughout the body.  A wide 
array of neuromuscular complications can 
occur secondary to neuronal damage.  
Nurse anesthetists must create an 
anesthetic plan for each MS patient he or 
she encounters individually, depending on 
the patient’s complications and degree of 
disease progression. 
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It is our duty as healthcare providers to 
educate our patients to ensure they 
have the information necessary to make 
informative decisions, preventing 
postoperative complications and 
decreasing the risk for exacerbation of 
symptoms related to MS. 
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